BET-ting on Nrf2: How Nrf2 Signaling can Influence the Therapeutic Activities of BET Protein Inhibitors

Chatterjee, N; Bohmann, D

Chatterjee, N (reprint author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Bohmann, D (reprint author), Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA.

BIOESSAYS, 2018; 40 (5):

Abstract

BET proteins such as Brd3 and Brd4 are chromatin-associated factors, which control gene expression programs that promote inflammation and cancer. The ......

Full Text Link